Posttranslational regulation of the NKG2D ligand Multl in response to cell stress

Journal of Experimental Medicine

Volumn 206, Issue 2, 2009, Pages 287-298

  Nice, Timothy J ^a   Coscoy, Laurent ^a   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; LYSINE; MURINE UL16 BINDING PROTEIN LIKE TRANSCRIPT 1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, MOUSE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PRIMER DNA; UL16 BINDING PROTEIN 1, MOUSE;

AMINO ACID SEQUENCE; ARTICLE; CELL STRESS; CELL SURFACE; CELLULAR STRESS RESPONSE; CYTOPLASM; DISEASE ASSOCIATION; GENOTOXICITY; HEAT SHOCK; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSLATION REGULATION; UBIQUITINATION; ULTRAVIOLET IRRADIATION; ANIMAL; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MOUSE; NATURAL KILLER CELL; PHYSIOLOGICAL STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPRECIPITATION; KILLER CELLS, NATURAL; LIGANDS; MICE; MICROSCOPY, FLUORESCENCE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, PHYSIOLOGICAL; UBIQUITINATION;

EID: 63049098026     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081335     Document Type: Article

References (45)

1. David H. Raulet Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, Berkeley, CA 94720 raulet@berkeley.edu 1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
2. Bukowski, J. F., B.A. Woda, and R.M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119-128.
3. Herberman, R.B., and J. R. Ortaldo. 1981. Natural killer cells: their roles in defenses against disease. Science. 214:24-30.
4. Raulet, D.H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781-790.
5. Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126.
6. Cosman, D., J. Mullberg, C.L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N.J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:123-133.
7. Cerwenka, A., A.B. Bakker, T. McClanahan, J. Wagner, J. Wu, J.H. Phillips, and L.L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:721-727.
8. Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:727-729.
9. Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:165-171.
10. Groh, V., R. Rhinehart, J. Randolph-Habecker, M.S. Topp, S.R. Riddell, and T. Spies. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255-260.
11. Pende, D., C. Cantoni, P. Rivera, M. Vitale, R. Castriconi, S. Marcenaro, M. Nanni, R. Biassoni, C. Bottino, A. Moretta, and L. Moretta. 2001. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 31:1076-1086.
12. Guerra, N., Y.X. Tan, N.T. Joncker, A. Choy, F. Gallardo, N. Xiong, S. Knoblaugh, D. Cado, N.R. Greenberg, and D.H. Raulet. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 28:571-580.
13. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K.H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA. 96:6879-6884.
14. Tieng, V., C. Le Bouguenec, L. du Merle, P. Bertheau, P. Desreumaux, A. Janin, D. Charron, and A. Toubert. 2002. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. USA. 99:2977-2982.
15. Venkataraman, G.M., D. Suciu, V. Groh, J. M. Boss, and T. Spies. 2007. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178:961-969.
16. Groh, V., S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA. 93:12445-12450.
17. Gasser, S., S. Orsulic, E.J. Brown, and D.H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 436:1186-1190.
18. Takada, A., S. Yoshida, M. Kajikawa, Y. Miyatake, U. Tomaru, M. Sakai, H. Chiba, K. Maenaka, D. Kohda, K. Fugo, and M. Kasahara. 2008. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J. Immunol. 180:1678-1685.
19. Diefenbach, A., J. K. Hsia, M.Y. Hsiung, and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macro- phages and induces tumor immunity. Eur. J. Immunol. 33:381-391.
20. Radosavljevic, M., B. Cuillerier, M.J. Wilson, O. Clement, S. Wicker, S. Gilfillan, S. Beck, J. Trowsdale, and S. Bahram. 2002. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics. 79:114-123.
21. Carayannopoulos, L.N., O.V. Naidenko, D.H. Fremont, and W.M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169:4079-4083.
22. Coscoy, L., D.J. Sanchez, and D. Ganem. 2001. A novel class of her- pesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155:1265-1273.
23. Shin, J.S., M. Ebersold, M. Pypaert, L. Delamarre, A. Hartley, and I. Mellman. 2006. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature. 444:115-118.
24. Bonifacino, J. S., and L.M. Traub. 2003. Signals for sorting of trans- membrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72:395-447.
25. Hicke, L., and R. Dunn. 2003. Regulation of membrane protein transport by ubiquitin and ubiquitin- binding proteins. Annu. Rev. Cell Dev. Biol. 19:141-172.
26. Schubert, U., D.E. Ott, E.N. Chertova, R. Welker, U. Tessmer, M.F. Princiotta, J. R. Bennink, H.G. Krausslich, and J. W. Yewdell. 2000. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. USA. 97:13057-13062.
27. Rosette, C., and M. Karin. 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cyto- kine receptors. Science. 274:1194-1197.
28. Maytin, E.V. 1992. Differential effects of heat shock and UVB light upon stress protein expression in epidermal keratinocytes. J. Biol. Chem. 267:23189-23196.
29. Cuesta, R., G. Laroia, and R.J. Schneider. 2000. Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev. 14:1460-1470.
30. Duncan, R., and J.W. Hershey. 1984. Heat shock-induced translational alterations in HeLa cells. Initiation factor modifications and the inhibition of translation. J. Biol. Chem. 259:11882-11889.
31. Adler, V., A. Schaffer, J. Kim, L. Dolan, and Z. Ronai. 1995. UV irradiation and heat shock mediate JNK activation via alternate pathways. J. Biol. Chem. 270:26071-26077.
32. Jolly, C., and R.I. Morimoto. 2000. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Inst. 92:1564-1572.
33. Garrido, C., M. Brunet, C. Didelot, Y. Zermati, E. Schmitt, and G. Kroemer. 2006. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 5:2592-2601.
34. Wu, B.J., H.C. Hurst, N.C. Jones, and R.I. Morimoto. 1986. The E1A 13S product of adenovirus 5 activates transcription of the cellular human HSP70 gene. Mol. Cell. Biol. 6:2994-2999.
35. Lindquist, S. 1986. The heat-shock response. Annu. Rev. Biochem. 55:1151- 1191.
36. Lyles, D.S. 2000. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol. Mol. Biol. Rev. 64:709-724.
37. Glaunsinger, B., and D. Ganem. 2004. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell. 13:713- 723.
38. Hoffman, E.S., L. Passoni, T. Crompton, T.M. Leu, D.G. Schatz, A. Koff, M.J. Owen, and A.C. Hayday. 1996. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10:948- 962.
39. Bartkova, J., Z. Horejsi, K. Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J.M. Nesland, C. Lukas, et al. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumori- genesis. Nature. 434:864- 870.
40. Gorgoulis, V.G., L.V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R.A. Ditullio Jr., N.G. Kastrinakis, B. Levy, et al. 2005. Activation of the DNA damage checkpoint and ge- nomic instability in human precancerous lesions. Nature. 434:907- 913.
41. Thomas, M., J.M. Boname, S. Field, S. Nejentsev, M. Salio, V. Cerundolo, M. Wills, and P.J. Lehner. 2008. Down-regulation of NKG2D and NKp80 ligands by Kaposi ' s sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA. 105:1656- 1661.
42. Bacon, L., R.A. Eagle, M. Meyer, N. Easom, N.T. Young, and J. Trowsdale. 2004. Two human ULBP/RAET1 molecules with trans- membrane regions are ligands for NKG2D. J. Immunol. 173:1078- 1084.
43. Meusser, B., C. Hirsch, E. Jarosch, and T. Sommer. 2005. ERAD: the long road to destruction. Nat. Cell Biol. 7:766- 772.
44. Krmpotic, A., M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. 2005. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201:211- 220.
45. Ranganath, S., W. Ouyang, D. Bhattarcharya, W.C. Sha, A. Grupe, G. Peltz, and K.M. Murphy. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822- 3826.